查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081314

醫療保健包裝市場預測（2034 年）—按包裝類型、產品類型、材料、應用、最終用戶和地區分類的全球分析

Healthcare Packaging Market Forecasts to 2034 - Global Analysis By Packaging Type, By Product Type, By Material, By Application, By End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球醫療保健包裝市場預計到 2026 年將達到 1,610 億美元，並在預測期內以 6.9% 的複合年成長率成長，到 2034 年達到 2,745 億美元。

醫療保健包裝包括用於藥品、醫療設備、生物製藥、診斷試劑和營養補充劑的容器、瓶蓋、標籤和保護材料。這些包裝解決方案必須滿足嚴格的監管要求，確保產品完整性，並具備防篡改功能，並根據需要保持無菌狀態。推動該市場發展的因素包括藥品產量增加、醫療保健支出上升、生物製藥需求成長以及藥物輸送系統的創新。塑膠、玻璃、紙張和紙板、鋁箔以及其他特殊材料等材料被廣泛應用於醫療保健領域的各種應用。

藥品產量增加和醫療成本上升

全球製藥業的成長和醫療保健支出的增加是推動醫療保健包裝需求的主要因素。隨著人口老化和慢性病的盛行率上升，藥品產量穩定成長，直接帶動了包裝需求。學名藥生產的擴張，尤其是在新興經濟體，對經濟高效的包裝解決方案產生了顯著需求。新冠疫情凸顯了醫療保健包裝在疫苗分發和醫療用品物流中的關鍵作用。開發中國家的政府醫療保健支出和私人醫療保健投資都在支持包裝需求的持續成長。藥品產量的穩定成長表明，醫療保健包裝市場將在預測期內持續穩定擴張。

嚴格的監管合規性和品質標準

醫療保健包裝的嚴格監管要求是一項重大阻礙因素，增加了包裝解決方案的開發成本和上市時間。醫療保健包裝必須符合涵蓋多個司法管轄區的複雜法規，包括美國藥典 (USP)、歐洲藥典 (EP)、美國食品藥物管理局 (FDA) 和國際標準化組織 (ISO) 標準。無菌產品的包裝需要進行驗證測試、穩定性測試和詳細的文件記錄，這顯著增加了成本。包裝的任何改動都需要向監管機構申請並獲得批准，限制了柔軟性。材料適用性測試、萃取物和洗脫物研究以及兒童安全蓋的要求進一步加劇了問題的複雜性。這些合規負擔是一項重大挑戰，尤其對於小規模製造商而言，可能會限制創新並減緩市場成長。

對永續和環保包裝的需求日益成長

人們對環境永續性的日益關注為醫療保健包裝領域的創新帶來了巨大機會。醫療保健行業因包裝而產生大量塑膠廢棄物，這加大了對環保替代品的需求。可回收塑膠解決方案、可生物分解材料和簡化包裝正日益受到關注。用於非無菌應用的紙質替代品減少了對塑膠的依賴。可回收塑膠吸塑包裝和採用水性黏合劑的環保標章正作為新興創新湧現。永續包裝策略不僅能帶來市場優勢，還能與企業的ESG（環境、社會和治理）目標相契合。隨著環境法規的日益嚴格和消費者期望的不斷變化，永續的醫療保健包裝解決方案正在推動市場差異化和成長。

原物料價格波動與供應鏈中斷

原料價格波動和供應鏈中斷對醫療保健包裝製造商構成重大威脅。塑膠樹脂價格與原油價格波動密切相關，直接影響包裝成本和盈利。玻璃製造需要高能耗工藝，其成本受能源價格波動的影響。紙張和紙板價格受紙漿供應、運輸成本和貿易政策的影響。供應鏈中斷，例如物流瓶頸、港口擁擠和地緣政治緊張局勢，會影響原料供應並推高成本。對原料和成品包裝產品徵收的關稅和貿易限制進一步加劇了全球供應鏈的挑戰。這些不確定性給包裝製造商及其客戶帶來了財務壓力。

新型冠狀病毒（COVID-19）的影響：

新冠疫情大大加速了醫療包裝材料的需求，同時也為供應鏈帶來了巨大挑戰。疫苗的生產和分發產生了前所未有的需求，包括對管瓶、注射器和低溫運輸包裝解決方案的需求。診斷檢測需求的增加也帶動了對檢測套組包裝的需求。醫療設備的生產也導致醫療設備包裝需求激增。然而，包括原料短缺、物流瓶頸和產能限制在內的供應鏈中斷影響了包裝材料的供應。原料和運輸成本的上漲進一步擠壓了盈利。疫情過後，在醫療支出增加、疫苗基礎設施投資以及醫療供應鏈強化的推動下，醫療包裝材料的需求仍然強勁。這場危機永久提升了醫療包裝材料的戰略重要性。

在預測期內，塑膠產業預計將佔據最大的市場佔有率。

由於塑膠具有用途廣泛、成本效益高以及適用於多種醫療應用等優點，預計在預測期內，塑膠領域將佔據最大的市場佔有率。塑膠具有優異的阻隔性、設計柔軟性、輕質特性，並且相容於多種滅菌方法，包括環氧乙烷滅菌和伽馬射線滅菌。其應用包括泡殼包裝、瓶子、管瓶、注射器、醫療設備托盤、包裝袋和瓶蓋。聚乙烯、聚丙烯和聚對苯二甲酸乙二醇酯（PET）廣泛應用於各種醫療保健包裝領域。該領域受益於持續的創新，包括增強阻隔性的塑膠、可回收材料和先進的成型技術。憑藉其在從製藥到診斷等所有醫療領域的廣泛應用，塑膠已鞏固了其在市場上的主導地位。

預計生物製劑產業在預測期內將呈現最高的複合年成長率。

在預測期內，生物製藥領域預計將呈現最高的成長率，這主要得益於生物製藥研發和生產的快速擴張。疫苗、單株抗體、細胞和基因療法等生物製藥產品需要專門的包裝解決方案，以維持產品穩定性、確保無菌性並防止污染。對溫度敏感的生物製藥產品需要具備隔熱和溫度監控功能的低溫運輸包裝。預填充式注射器和帶有阻隔塗層的專用管瓶是生物製藥包裝的必備品。個人化醫療和生物相似藥的成長也進一步推動了對生物製藥包裝的需求。由於生物製藥是製藥業成長最快的領域，其相關的包裝領域也預計將呈現優異的成長率。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其先進的醫療基礎設施、強大的藥品生產能力和嚴格的監管標準。該地區匯聚了許多主要企業（製藥公司和醫療設備製造商），從而產生了對醫療包裝的穩定需求。高昂的醫療費用支出和完善的供應鏈進一步推動了市場成長。主要包裝製造商的存在以及在材料和設計方面的持續創新，鞏固了北美的市場主導地位。政府為促進國內藥品生產和醫療安全而採取的措施也支撐了持續的需求。成熟的醫療體系和強大的產業影響力確保了北美保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於藥品製造業的擴張、醫療保健支出的成長以及醫療設備產量的增加。中國、印度和東南亞等國家的製藥業正在快速發展，顯著提升了包裝的需求。政府為促進國內藥品和醫療設備生產的舉措，進一步加速了包裝消費。公眾健康意識的提高和醫療服務覆蓋範圍的擴大也推動了藥品消費的成長。該地區的契約製造組織（CMO）為全球製藥公司提供服務，從而創造了穩定的包裝需求。隨著醫療保健產業的擴張和生產能力的提升，亞太地區正經歷最快的市場成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球醫療保健包裝市場：依包裝類型分類

  • 初級包裝
  • 二級包裝
  • 三級包裝

第6章 全球醫療保健包裝市場：依產品類型分類

  • 瓶子和容器
  • 吸塑包裝
  • 管瓶和安瓿
  • 小袋和袋子
  • 預填充式注射器
  • 標籤和插頁
  • 其他產品類型

第7章 全球醫療保健包裝市場：依材料分類

  • 塑膠
  • 玻璃
  • 紙張和紙板
  • 鋁箔
  • 其他材料

第8章 全球醫療保健包裝市場：按應用分類

  • 製藥
  • 醫療器材
  • 生物製劑
  • 診斷
  • 營養保健品

第9章 全球醫療保健包裝市場：依最終用戶分類

  • 製藥公司
  • 醫療設備製造商
  • 合約包裝業務
  • 醫院和診所
  • 診斷中心

第10章 全球醫療保健包裝市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Amcor plc
  • Berry Global Group, Inc.
  • Sonoco Products Company
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • AptarGroup, Inc.
  • Becton, Dickinson and Company
  • Schott AG
  • SGD Pharma
  • Catalent, Inc.
  • Sealed Air Corporation
  • DuPont de Nemours, Inc.
  • Constantia Flexibles Group GmbH
  • Nelipak Corporation
  • Oliver Healthcare Packaging Company
  • Tekni-Plex, Inc.
  • WestRock Company
  • CCL Industries Inc.
Product Code: SMRC37796

According to Stratistics MRC, the Global Healthcare Packaging Market is accounted for $161.0 billion in 2026 and is expected to reach $274.5 billion by 2034 growing at a CAGR of 6.9% during the forecast period. Healthcare packaging encompasses containers, closures, labels, and protective materials used for pharmaceutical products, medical devices, biologics, diagnostics, and nutraceuticals. These packaging solutions must meet stringent regulatory requirements, ensure product integrity, provide tamper-evident features, and maintain sterility where required. The market is driven by increasing pharmaceutical production, growing healthcare expenditure, rising demand for biologics, and innovations in drug delivery systems. Materials including plastic, glass, paper and paperboard, aluminum foil, and other specialized materials serve diverse applications across the healthcare sector.

Market Dynamics:

Driver:

Rising pharmaceutical production and healthcare expenditure

The growing global pharmaceutical industry and increasing healthcare expenditure are primary drivers for healthcare packaging demand. As populations age and chronic diseases become more prevalent, pharmaceutical production volumes continue rising, directly increasing packaging requirements. The expansion of generic drug manufacturing, particularly in emerging economies, creates substantial demand for cost-effective packaging solutions. The COVID-19 pandemic highlighted the critical role of healthcare packaging in vaccine distribution and medical supply logistics. Government healthcare spending and private healthcare investments across developed and developing regions support sustained packaging demand. This consistent growth in pharmaceutical output ensures steady healthcare packaging market expansion throughout the forecast period.

Restraint:

Strict regulatory compliance and quality standards

Stringent regulatory requirements for healthcare packaging represent a significant restraint, increasing development costs and time-to-market for packaging solutions. Healthcare packaging must comply with complex regulations across multiple jurisdictions, including USP, EP, FDA, and ISO standards. Packaging for sterile products requires validation testing, stability studies, and extensive documentation, adding substantial costs. Any packaging changes require regulatory submissions and approvals, limiting flexibility. Material compatibility testing, extractable and leachable studies, and child-resistant closure requirements add further complexity. These compliance burdens are particularly challenging for smaller manufacturers and may limit innovation, potentially slowing market growth.

Opportunity:

Growing demand for sustainable and eco-friendly packaging

The increasing focus on environmental sustainability presents significant opportunities for healthcare packaging innovation. Healthcare generates substantial plastic waste from packaging, creating pressure for eco-friendly alternatives. Recyclable plastic solutions, biodegradable materials, and reduced packaging designs are gaining traction. Paper-based alternatives for non-sterile applications reduce plastic dependence. Recyclable plastic blister packaging and eco-friendly labels with water-based adhesives are emerging innovations. Sustainable packaging strategies offer marketing advantages and align with corporate ESG goals. As environmental regulations tighten and consumer expectations evolve, sustainable healthcare packaging solutions drive market differentiation and growth.

Threat:

Fluctuating raw material prices and supply chain disruptions

Volatility in raw material prices and supply chain disruptions pose significant threats to healthcare packaging manufacturers. Plastic resin prices track crude oil fluctuations, directly impacting packaging costs and profitability. Glass production requires energy-intensive processes, with costs affected by energy price volatility. Paper and paperboard prices vary with pulp availability, transportation costs, and trade policies. Supply chain disruptions including logistics bottlenecks, port congestion, and geopolitical tensions affect raw material availability and increase costs. Tariffs and trade restrictions on raw materials or finished packaging products further challenge global supply chains. These uncertainties create financial pressures for packaging manufacturers and their customers.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated healthcare packaging demand while creating significant supply chain challenges. Vaccine production and distribution created unprecedented demand for vials, syringes, and cold-chain packaging solutions. Diagnostic testing requirements increased demand for test kit packaging. Medical device packaging demand surged alongside medical equipment production. However, supply chain disruptions including raw material shortages, logistics bottlenecks, and production capacity constraints affected packaging availability. Increased raw material costs and transportation expenses further challenged profitability. Post-pandemic, healthcare packaging demand continues sustained, driven by increased healthcare spending, vaccine infrastructure investments, and strengthened medical supply chains. The crisis permanently elevated healthcare packaging's strategic importance.

The Plastic segment is expected to be the largest during the forecast period

The Plastic segment is expected to account for the largest market share during the forecast period, driven by its versatility, cost-effectiveness, and suitability for diverse healthcare applications. Plastic offers excellent barrier properties, design flexibility, lightweight characteristics, and compatibility with sterilization methods including ethylene oxide and gamma irradiation. Applications include blister packs, bottles, vials, syringes, medical device trays, pouches, and closures. Polyethylene, polypropylene, and PET are widely used for various healthcare packaging applications. The segment benefits from continuous innovation including barrier-enhanced plastics, recyclable materials, and advanced molding technologies. Plastic's broad applicability across all healthcare categories from pharmaceuticals to diagnostics ensures its dominant market position.

The Biologics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Biologics segment is predicted to witness the highest growth rate, fueled by the rapid expansion of biologic drug development and manufacturing. Biologics including vaccines, monoclonal antibodies, and cell and gene therapies require specialized packaging solutions that maintain product stability, ensure sterility, and protect against contamination. Temperature-sensitive biologics demand cold-chain packaging with thermal protection and temperature monitoring capabilities. Prefilled syringes and specialized vials with barrier coatings are essential for biologic packaging. The growth of personalized medicine and biosimilars further drives biologic packaging demand. As biologics represent the fastest-growing pharmaceutical category, the associated packaging segment delivers superior growth rates.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare infrastructure, strong pharmaceutical production, and stringent regulatory standards. The region is home to many leading pharmaceutical and medical device companies, creating consistent demand for healthcare packaging. Significant healthcare expenditure and well-established supply chains further support market growth. Presence of major packaging manufacturers and continuous innovation in materials and designs contribute to market leadership. Government initiatives promoting domestic pharmaceutical production and healthcare security support sustained demand. With mature healthcare systems and strong industry presence, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by expanding pharmaceutical manufacturing, growing healthcare expenditure, and increasing medical device production. Countries including China, India, and Southeast Asian nations are experiencing rapid pharmaceutical industry growth, creating substantial packaging demand. Government initiatives promoting domestic pharmaceutical and medical device manufacturing further accelerate packaging consumption. Rising healthcare awareness and increasing access to healthcare services expand pharmaceutical consumption. Contract manufacturing organizations in the region serve global pharmaceutical companies, generating consistent packaging requirements. As healthcare sectors expand and manufacturing capabilities grow, Asia Pacific delivers the fastest market growth.

Key players in the market

Some of the key players in Healthcare Packaging Market include Amcor plc, Berry Global Group, Inc., Sonoco Products Company, West Pharmaceutical Services, Inc., Gerresheimer AG, AptarGroup, Inc., Becton, Dickinson and Company, Schott AG, SGD Pharma, Catalent, Inc., Sealed Air Corporation, DuPont de Nemours, Inc., Constantia Flexibles Group GmbH, Nelipak Corporation, Oliver Healthcare Packaging Company, Tekni-Plex, Inc., WestRock Company, and CCL Industries Inc.

Key Developments:

In April 2026, Gerresheimer partnered with Milliken to roll out its new LeneX UltraGuard(R) technology, introducing advanced barrier properties to enhance the performance and shelf-life protection of primary plastic pharmaceutical containers.

In April 2026, Berry Global Group completed its definitive merger with Amcor plc to consolidate the production of sustainable, lightweight thermoformed trays, pharmaceutical bottles, and sterile barrier systems under a unified global enterprise.

In April 2026, Amcor announced a $35 million USD expansion in Selangor, Malaysia, opening an advanced healthcare packaging coating facility equipped with air-knife technology to manufacture high-precision coated medical paper for sterile device packaging in Southeast Asia.

In January 2026, West officially rebranded its Contract-Manufactured Products reportable division to West Vantage(TM) to better highlight its comprehensive design-to-manufacturing scale for custom biopharmaceutical and diagnostic device packaging.

Packaging Types Covered:

  • Primary Packaging
  • Secondary Packaging
  • Tertiary Packaging

Product Types Covered:

  • Bottles and Containers
  • Blister Packs
  • Vials and Ampoules
  • Pouches and Bags
  • Prefilled Syringes
  • Labels and Inserts
  • Other Product Types

Materials Covered:

  • Plastic
  • Glass
  • Paper and Paperboard
  • Aluminum Foil
  • Other Materials

Applications Covered:

  • Pharmaceuticals
  • Medical Devices
  • Biologics
  • Diagnostics
  • Nutraceuticals

End Users Covered:

  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • Contract Packaging Organizations
  • Hospitals and Clinics
  • Diagnostic Centers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Packaging Market, By Packaging Type

  • 5.1 Primary Packaging
  • 5.2 Secondary Packaging
  • 5.3 Tertiary Packaging

6 Global Healthcare Packaging Market, By Product Type

  • 6.1 Bottles and Containers
  • 6.2 Blister Packs
  • 6.3 Vials and Ampoules
  • 6.4 Pouches and Bags
  • 6.5 Prefilled Syringes
  • 6.6 Labels and Inserts
  • 6.7 Other Product Types

7 Global Healthcare Packaging Market, By Material

  • 7.1 Plastic
  • 7.2 Glass
  • 7.3 Paper and Paperboard
  • 7.4 Aluminum Foil
  • 7.5 Other Materials

8 Global Healthcare Packaging Market, By Application

  • 8.1 Pharmaceuticals
  • 8.2 Medical Devices
  • 8.3 Biologics
  • 8.4 Diagnostics
  • 8.5 Nutraceuticals

9 Global Healthcare Packaging Market, By End User

  • 9.1 Pharmaceutical Companies
  • 9.2 Medical Device Manufacturers
  • 9.3 Contract Packaging Organizations
  • 9.4 Hospitals and Clinics
  • 9.5 Diagnostic Centers

10 Global Healthcare Packaging Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Amcor plc
  • 13.2 Berry Global Group, Inc.
  • 13.3 Sonoco Products Company
  • 13.4 West Pharmaceutical Services, Inc.
  • 13.5 Gerresheimer AG
  • 13.6 AptarGroup, Inc.
  • 13.7 Becton, Dickinson and Company
  • 13.8 Schott AG
  • 13.9 SGD Pharma
  • 13.10 Catalent, Inc.
  • 13.11 Sealed Air Corporation
  • 13.12 DuPont de Nemours, Inc.
  • 13.13 Constantia Flexibles Group GmbH
  • 13.14 Nelipak Corporation
  • 13.15 Oliver Healthcare Packaging Company
  • 13.16 Tekni-Plex, Inc.
  • 13.17 WestRock Company
  • 13.18 CCL Industries Inc.

List of Tables

  • Table 1 Global Healthcare Packaging Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Healthcare Packaging Market Outlook, By Packaging Type (2023-2034) ($MN)
  • Table 3 Global Healthcare Packaging Market Outlook, By Primary Packaging (2023-2034) ($MN)
  • Table 4 Global Healthcare Packaging Market Outlook, By Secondary Packaging (2023-2034) ($MN)
  • Table 5 Global Healthcare Packaging Market Outlook, By Tertiary Packaging (2023-2034) ($MN)
  • Table 6 Global Healthcare Packaging Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 7 Global Healthcare Packaging Market Outlook, By Bottles and Containers (2023-2034) ($MN)
  • Table 8 Global Healthcare Packaging Market Outlook, By Blister Packs (2023-2034) ($MN)
  • Table 9 Global Healthcare Packaging Market Outlook, By Vials and Ampoules (2023-2034) ($MN)
  • Table 10 Global Healthcare Packaging Market Outlook, By Pouches and Bags (2023-2034) ($MN)
  • Table 11 Global Healthcare Packaging Market Outlook, By Prefilled Syringes (2023-2034) ($MN)
  • Table 12 Global Healthcare Packaging Market Outlook, By Labels and Inserts (2023-2034) ($MN)
  • Table 13 Global Healthcare Packaging Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 14 Global Healthcare Packaging Market Outlook, By Material (2023-2034) ($MN)
  • Table 15 Global Healthcare Packaging Market Outlook, By Plastic (2023-2034) ($MN)
  • Table 16 Global Healthcare Packaging Market Outlook, By Glass (2023-2034) ($MN)
  • Table 17 Global Healthcare Packaging Market Outlook, By Paper and Paperboard (2023-2034) ($MN)
  • Table 18 Global Healthcare Packaging Market Outlook, By Aluminum Foil (2023-2034) ($MN)
  • Table 19 Global Healthcare Packaging Market Outlook, By Other Materials (2023-2034) ($MN)
  • Table 20 Global Healthcare Packaging Market Outlook, By Application (2023-2034) ($MN)
  • Table 21 Global Healthcare Packaging Market Outlook, By Pharmaceuticals (2023-2034) ($MN)
  • Table 22 Global Healthcare Packaging Market Outlook, By Medical Devices (2023-2034) ($MN)
  • Table 23 Global Healthcare Packaging Market Outlook, By Biologics (2023-2034) ($MN)
  • Table 24 Global Healthcare Packaging Market Outlook, By Diagnostics (2023-2034) ($MN)
  • Table 25 Global Healthcare Packaging Market Outlook, By Nutraceuticals (2023-2034) ($MN)
  • Table 26 Global Healthcare Packaging Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Healthcare Packaging Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
  • Table 28 Global Healthcare Packaging Market Outlook, By Medical Device Manufacturers (2023-2034) ($MN)
  • Table 29 Global Healthcare Packaging Market Outlook, By Contract Packaging Organizations (2023-2034) ($MN)
  • Table 30 Global Healthcare Packaging Market Outlook, By Hospitals and Clinics (2023-2034) ($MN)
  • Table 31 Global Healthcare Packaging Market Outlook, By Diagnostic Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.